Cargando…

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer

Recent studies, including a meta-analysis of 88 trials, have shown higher than expected rates of recurrence and death in hormone receptor–positive breast cancer. These new findings suggest a need to re-evaluate the use of risk-reducing medication to avoid invasive breast cancer and breast cancer dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayasekera, Jinani, Zhao, Amy, Schechter, Clyde, Lowry, Kathryn, Yeh, Jennifer M., Schwartz, Marc D., O'Neill, Suzanne, Wernli, Karen J., Stout, Natasha, Mandelblatt, Jeanne, Kurian, Allison W., Isaacs, Claudine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901948/ https://www.ncbi.nlm.nih.gov/pubmed/36455167 http://dx.doi.org/10.1200/JCO.22.01342

Ejemplares similares

Simulation modeling of breast cancer endocrine therapy duration by patient and tumor characteristics
por: Chandler, Young, et al.
Publicado: (2021)

Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Development and Validation of a Simulation Model–Based Clinical Decision Tool: Identifying Patients Where 21-Gene Recurrence Score Testing May Change Decisions
por: Jayasekera, Jinani, et al.
Publicado: (2021)

Effect of Personalized Breast Cancer Risk Tool on Chemoprevention and Breast Imaging: ENGAGED-2 Trial
por: Wernli, Karen J, et al.
Publicado: (2021)

Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts
por: Trentham-Dietz, Amy, et al.
Publicado: (2021)

Using Protection Motivation Theory to Predict Intentions for Breast Cancer Risk Management: Intervention Mechanisms from a Randomized Controlled Trial
por: Conley, Claire C., et al.
Publicado: (2021)

Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women
por: van Ravesteyn, Nicolien T, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling
por: Alagoz, Oguzhan, et al.
Publicado: (2021)

A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer
por: Zhao, Amy, et al.
Publicado: (2021)

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History
por: van den Broek, Jeroen J, et al.
Publicado: (2020)

Which Strategies Reduce Breast Cancer Mortality Most?: Collaborative Modeling of Optimal Screening, Treatment, and Obesity Prevention
por: Mandelblatt, Jeanne, et al.
Publicado: (2013)

Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting
por: Cao, Pianpian, et al.
Publicado: (2022)

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality
por: Chang, Yaojen, et al.
Publicado: (2012)

Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
por: Caswell-Jin, Jennifer L, et al.
Publicado: (2018)

A careful reassessment of anthracycline use in curable breast cancer
por: Hurvitz, Sara Alsterlind, et al.
Publicado: (2021)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?
por: Mandelblatt, Jeanne, et al.
Publicado: (2003)

Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider
por: Black, Lee, et al.
Publicado: (2012)

Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences
por: Peccatori, Fedro Alessandro, et al.
Publicado: (2018)

Epidemiological Determinants of Advanced Prostate Cancer in Elderly Men in the United States
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and Future Potential for Intervention Research
por: Kehm, Rebecca D., et al.
Publicado: (2020)

Evidence-based sizing of non-inferiority trials using decision models
por: Lansdorp-Vogelaar, Iris, et al.
Publicado: (2019)

Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic
por: Lowry, Kathryn P., et al.
Publicado: (2021)

EPIGENETIC AGING IN OLDER BREAST CANCER SURVIVORS: THE THINKING AND LIVING WITH CANCER (TLC) STUDY
por: Rentscher, Kelly, et al.
Publicado: (2022)

Factors to Consider in the Association Between Soy Isoflavone Intake and Breast Cancer Risk
por: Nagata, Chisato
Publicado: (2010)

An ecological approach to monitor geographic disparities in cancer outcomes
por: Jayasekera, Jinani, et al.
Publicado: (2019)

Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support
por: Evans, Chalanda, et al.
Publicado: (2016)

Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
por: Vilaprinyo, Ester, et al.
Publicado: (2014)

PLAC1 as a serum biomarker for breast cancer
por: Yuan, Hongyan, et al.
Publicado: (2018)

Interconnected Clinical and Social Risk Factors in Breast Cancer and Heart Failure
por: Sinha, Arjun, et al.
Publicado: (2022)

Relative harms and merits of postoperative radiation following conservative surgery for low risk breast cancer
por: Holli, K, et al.
Publicado: (2002)

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
por: Eisen, Andrea, et al.
Publicado: (2008)

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Decisional conflict in breast cancer patients considering immediate breast reconstruction
por: ter Stege, Jacqueline A., et al.
Publicado: (2020)

Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening
por: Knudsen, Amy B., et al.
Publicado: (2023)

Benefits and harms of breast cancer screening: Cohort study of breast cancer mortality and overdiagnosis
por: Wang, Sabrina, et al.
Publicado: (2023)

Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2021)

Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2005)

Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment
por: Dinapoli, Loredana, et al.
Publicado: (2021)

Breast cancer relapses considering molecular biological characteristics
por: Smolanka, Ivan Ivanovich, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gdgll8meo5et6vf0g3pccbip48